We spoke to Professor Jean-François Obadia (Civils Hospices of Lyon, Lyon, France) about the 2-year follow up from the MITRA-FR trial, and how he would interpret the differing results from recent studies into the efficacy of the MitraClip in patients with mitral regurgitation. Finally, he touches on which patients might be likely to benefit from the intervention and how physicians can best identify them.
Speaker’s Disclosures: Jean-François Obadia has received research grants from Abbott and the French Ministry of Health and is a consultant for Dealcroix-Chevalier, Lanadanger, Medtronic, SJM (Abbott), Novartis and Sorin.
1. What update can you provide from the 2-year follow up of the MITRA-FR trial? (0:05)
2. How would you interpret the differing results between recent studies into the efficacy of MitraClip in patients with mitral regurgitation? (1:00)
3. How can physicians identify patients most likely to benefit from this intervention? (1:44)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed at the European Society of Cardiology (ESC) Congress 2019 in Paris, France, September 2019.
Share this Video
Related Videos In Hypertension
Ajay Kirtane, TCT 2022: The benefits of ultrasound renal denervation for patients with uncontrolled hypertension, the RADIANCE II trial
The RADIANCE II trial aimed to build on existing data to demonstrate that ultrasound renal denervation can lower blood pressure in patients with uncontrolled hypertension. In this touchCARDIO interview, we speak with Dr Ajay Kirtane (Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, NY, USA) to discuss the outcomes of the RADIANCE II trial […]
Ajay Kirtane, TCT 2022: Ultrasound renal denervation, a tool for uncontrolled hypertension
Despite medications and lifestyle modifications for hypertension, there are still many cases of uncontrolled hypertension. Ultrasound renal denervation has shown to be a tool for reducing blood pressure. In this touchCARDIO interview, we speak with Dr Ajay Kirtane (Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, NY, USA) to discuss the challenges faced in […]
Maura Marcucci, ACC 2022: POISE-3: The effects of a hypotension-avoidance strategy versus a hypertension-avoidance strategy in patients undergoing noncardiac surgery
The POISE-3 study assessed the effects of a hypotension-avoidance strategy versus a hypertension-avoidance strategy in patients undergoing noncardiac surgery. touchCARDIO spoke to Dr Maura Marcucci (McMaster University, Hamilton, Ontario, Canada) to discuss her presentation of the results of the POSE-3 study at the American College of Cardiology Annual Meeting 2022. Questions Could […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!